FindTrial
Sign In

A clinical study to evaluate the efficacy of Darvyadi Leha in Kamla in grabhini or jaundice in pregnancy

A Clinical Study To Evaluate The Efficacy Of Darvyadi Leha in Garbhini Kamla w.s.r. to Intrahepatic Cholestasis Of Pregnancy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/04/032854
Enrollment
30
Registered
2021-04-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O266- Liver and biliary tract disordersin pregnancy, childbirth and the puerperium

Interventions

Intervention1: Darvyadi leha: Dose : 10gm Bd Intervention2: Ursodeoxycholic acid: 14mg/kg/day Control Intervention1: Not applicable: Not applicable

Sponsors

RGG PG Ayurvedic College And Hospital Paprola
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient willing for trial . Female patient presenting with features of Garbhini kamala Pregnant females presenting the picture of impaired liver functions

Exclusion criteria

Exclusion criteria: Patient not willing for trial Patient having eclampsia , HELLP ,severe hyperemesis gravidarum, severe pre eclampsia , viral hepatitis , drug induced jaundice , cirrhosis, tumors and other systemic disorders, fatty liver

Design outcomes

Primary

MeasureTime frame
Fulfillment of subjective and objective criterionTimepoint: 7-15 days—

Secondary

MeasureTime frame
Feeling of well beingTimepoint: 7-15 days—

Countries

India

Contacts

Public ContactDr Ekta

Rajiv Gandhi Govt Post graduate Ayurvedic College and Hospital Paprola

drseemanil@gmail.com9418008833

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026